Literature DB >> 20539239

A case of immune thrombocytopenic purpura after influenza vaccination: consequence or coincidence?

Elpis Mantadakis1, Evangelia Farmaki, Stavros Thomaidis, Aggelos Tsalkidis, Athanassios Chatzimichael.   

Abstract

SUMMARY: The researchers describe the case of a earlier healthy 3-year-old boy, who developed immune thrombocytopenic purpura (ITP) 26 days after immunization with the second dose of seasonal influenza vaccine. He recovered quickly and uneventfully within 2 days after receiving a single dose of intravenous immunoglobulin. Review of the medical literature showed that symptomatic thrombocytopenia occurs in a substantial number of children and adults who require hospitalization for complicated natural influenza infection, particularly avian influenza. In contrast, it is exceptionally rare after influenza immunization, as only few case reports describe such an association in adults but not in children. As the risk of thrombocytopenia after natural influenza seems to be much higher than after immunization, annual influenza vaccination is advised for patients with personal history of ITP who at risk of influenza-related complications owing to underlying medical problems.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20539239     DOI: 10.1097/MPH.0b013e3181e33fe0

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  8 in total

Review 1.  Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.

Authors:  Carlo Perricone; Fulvia Ceccarelli; Gideon Nesher; Elisabetta Borella; Qasim Odeh; Fabrizio Conti; Yehuda Shoenfeld; Guido Valesini
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 2.  Vaccine administration and the development of immune thrombocytopenic purpura in children.

Authors:  Valerio Cecinati; Nicola Principi; Letizia Brescia; Paola Giordano; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

Review 3.  Clinical practice: immune thrombocytopenia in paediatrics.

Authors:  Veerle Labarque; Chris Van Geet
Journal:  Eur J Pediatr       Date:  2014-01-05       Impact factor: 3.183

4.  Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine.

Authors:  Vrushali Saudagar; Satish Patil; Shaun Goh; Sohil Pothiawala
Journal:  Ir J Med Sci       Date:  2021-03-31       Impact factor: 2.089

5.  Severe Immune Thrombocytopenic Purpura Following Influenza Vaccination: A Case Report.

Authors:  Ryuichi Ohta; Chiaki Sano
Journal:  Cureus       Date:  2022-01-14

Review 6.  Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review.

Authors:  Takuto Shonai; Fumihiko Kimura; Junichi Watanabe
Journal:  Intern Med       Date:  2022-03-19       Impact factor: 1.282

7.  The Frequency and Patterns of Post-COVID-19 Vaccination Syndrome Reveal Initially Mild and Potentially Immunocytopenic Signs in Primarily Young Saudi Women.

Authors:  Kamaleldin B Said; Amal Al-Otaibi; Luluh Aljaloud; Basmah Al-Anazi; Ahmed Alsolami; Fayez Saud Alreshidi
Journal:  Vaccines (Basel)       Date:  2022-06-24

8.  Postinfluenza Vaccination Idiopathic Thrombocytopenic Purpura in Three Elderly Patients.

Authors:  Joji Nagasaki; Masahiro Manabe; Kentaro Ido; Hiroyoshi Ichihara; Yasutaka Aoyama; Tadanobu Ohta; Yoshio Furukawa; Atsuko Mugitani
Journal:  Case Rep Hematol       Date:  2016-02-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.